Empagliflozin 25mg
$165.00 – $420.00

| Product name | Voglibose 0.3mg |
|---|---|
| Active Ingredient | Voglibose |
| Dosage | 0.3mg |
| Drug Type | Tablets |
| Indication | Type 2 Diabetes |
| Manufacturer | Sun Pharma |
Total $55.80
Voglibose 0.3mg Tablet is a prescription anti-diabetic medicine used to control type 2 diabetes mellitus (a long-term condition where blood sugar levels remain high due to reduced insulin action or delayed glucose metabolism).
This medicine belongs to the alpha-glucosidase inhibitor class (drugs that slow down carbohydrate digestion and reduce post-meal blood sugar spikes). It is mainly used to manage blood sugar after meals.
Doctors, especially diabetologists (specialists in diabetes management) and endocrinologists, prescribe Voglibose 0.3mg Tablet as part of a comprehensive diabetes control plan.
When we eat food containing carbohydrates such as rice, bread, or sweets, the body breaks them down into glucose (sugar), which enters the bloodstream.
In people with diabetes, this process can cause a rapid increase in blood sugar levels after meals.
This leads to postprandial hyperglycemia (a condition where blood sugar rises sharply after eating).
Over time, repeated spikes in blood sugar can increase the risk of complications such as nerve damage, kidney disease, and heart problems.
Voglibose 0.3mg Tablet works in the digestive system to slow down the breakdown of carbohydrates.
It reduces the speed at which complex carbohydrates are converted into glucose.
This helps prevent sudden spikes in blood sugar after meals and keeps glucose levels more stable.
Voglibose 0.3mg Tablet is mainly used for the management of type 2 diabetes mellitus.
It is especially useful in controlling post-meal blood sugar levels, which are difficult to manage with diet alone.
It is often prescribed along with other anti-diabetic medicines such as metformin or sulfonylureas when additional blood sugar control is needed.
It is used as part of a long-term diabetes management plan that also includes diet control, exercise, and lifestyle modification.
Regular use helps reduce the risk of diabetes-related complications caused by repeated blood sugar spikes.
Voglibose 0.3mg Tablet works in the small intestine, where food digestion takes place.
It inhibits alpha-glucosidase enzymes (digestive enzymes responsible for breaking down complex carbohydrates into simple sugars like glucose).
When these enzymes are blocked, carbohydrates are broken down more slowly.
This delays the absorption of glucose into the bloodstream.
As a result, blood sugar levels rise gradually instead of spiking suddenly after meals.
This helps maintain better overall glucose control throughout the day.
Some patients may experience mild side effects, especially during the initial days of treatment.
A common effect is gas formation or flatulence, due to undigested carbohydrates reaching the large intestine.
Some individuals may experience abdominal discomfort or bloating.
In some cases, diarrhea or loose stools may occur, especially if diet is not adjusted properly.
Rarely, stomach cramps or mild indigestion may be seen.
These side effects are usually temporary and improve as the body adapts to the medicine and dietary adjustments are made.
Voglibose 0.3mg Tablet should be taken exactly as prescribed by the doctor, usually just before meals.
It should be taken with the first bite of food for best effect.
Patients should follow a proper diet plan, as high carbohydrate intake may increase digestive side effects.
Regular monitoring of blood glucose levels is important to assess treatment effectiveness.
Patients should inform their doctor if they experience frequent stomach discomfort or persistent diarrhea.
It should not be used as a substitute for diet control or other diabetes medicines.
This content is for educational purposes only. It is not a substitute for medical advice. Voglibose 0.3mg Tablet should be used after proper medical evaluation for type 2 diabetes mellitus. It is commonly prescribed by a diabetologist or endocrinologist.